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ABSTRACT 
 
Introduction: Treatments of breast cancer are multidisciplinary. Chemotherapy is 
one of the most important modalities and has become the standard of breast cancer  
treatment of in the adjuvant or neoadjuvant setting.  Evaluation is needed in order to 
understand the effectivity of the chemotherapy regiment, to improve the service 
system and to share with other centers. Objectives: to understand the  
characteristics of chemotherapy patients, types of regimen, settings chemotherapy 
and neoadjuvant chemotherapy response of breast cancer. Methods: A 
retrospective study was done by reviewing the administrative data of cancer patients 
who were treated in the surgical oncology Wahidin Sudirohusodo Hospital, Makassar 
in 2014. Results: During 2014 has been carried out chemotherapy for 247 breast 
cancer patients, used as neoadjuvan setting 145 cases (59 %) and Adjuvan  102 
cases (41%).   The regimen used are CAF 155 cases ( 63%), TAC 55 cases  ( 22  
%), TA 20 cases (8%), GC 11 cases ( 5%), dan Vinoralbine 6 cases (2%).  
Cumulative Clinical Response are:  complete response 3 cases (2%),  partial 
response 112 cases (78%), stable disease 23 cases (15%),  and progresive disease 
9 (5%).  Chemoterapy response by subtype: Luminal 67%,  Her2 70%, Triple Negatif 
88%. Conclusions: Breast cancer clinical response to various chemotherapy 
regimens are good, regimen and subtype affect the response to chemotherapy. 
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